Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.04B | $2.90B | $2.81B | $2.82B | $2.76B | $2.65B | $2.62B | $2.49B |
| Cost of revenue | $2.02B | $1.95B | $1.90B | $1.87B | $1.82B | $1.79B | $1.76B | $1.68B |
| Gross profit | $1.03B | $942.00M | $910.00M | $949.00M | $943.00M | $863.00M | $858.00M | $811.00M |
| Gross margin | 33.7% | 32.5% | 32.4% | 33.7% | 34.2% | 32.5% | 32.7% | 32.6% |
| Selling, general and administrative | $529.00M | $504.00M | $504.00M | $501.00M | $486.00M | $476.00M | $466.00M | $448.00M |
| Operating expenses | $568.00M | $541.00M | $541.00M | $540.00M | $505.00M | $515.00M | $503.00M | $480.00M |
| Operating income | $459.00M | $401.00M | $369.00M | $409.00M | $438.00M | $348.00M | $355.00M | $331.00M |
| Operating margin | 15.1% | 13.9% | 13.2% | 14.5% | 15.9% | 13.1% | 13.5% | 13.3% |
| EBITDA | $605.00M | $548.00M | $514.00M | $551.00M | $581.00M | $488.00M | $490.00M | $456.00M |
| Interest income | $0 | −$63.00M | −$64.00M | −$66.00M | $0 | −$67.00M | −$65.00M | −$49.00M |
| Interest expense | −$63.00M | $0 | $0 | — | −$67.00M | $0 | $0 | — |
| Income before taxes | $422.00M | $334.00M | $330.00M | $328.00M | $393.00M | $276.00M | $299.00M | $296.00M |
| Income taxes | $88.00M | $74.00M | $81.00M | $77.00M | $97.00M | $59.00M | $68.00M | $65.00M |
| Net income | $334.00M | $264.00M | $256.00M | $259.00M | $296.00M | $235.00M | $236.00M | $237.00M |
| Net margin | 11.0% | 9.1% | 9.1% | 9.2% | 10.7% | 8.9% | 9.0% | 9.5% |
| EPS, basic | $2.88 | $2.27 | $2.22 | $2.18 | $2.51 | $1.97 | $1.98 | $2.01 |
| EPS, diluted | $2.84 | $2.24 | $2.17 | $2.16 | $2.47 | $1.94 | $1.94 | $1.99 |
| Diluted shares | 112.00M | 112.00M | 113.00M | 113.00M | 113.00M | 113.00M | 113.46M | 113.00M |
Figures describe Quest Diagnostics shares, not any token. As of Jul 23, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.